Evidence map›Paper›PMID 39009376›Full record

ArticleIntestinal research2024

Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findings.

Katsuki Yaguchi, Reiko Kunisaki, Sho Sato, Kaori Hirai, Misato Izumi, Yoshimi Fukuno, Mami Tanaka, Mai Okazaki, Rongrong Wu, Yurika Nishikawa and 16 more

Abstract read
In one paragraph

Article in Intestinal research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Behçet's Syndrome.Current rheumatology reports · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Katsuki YaguchiInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Reiko KunisakiInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Sho SatoDepartment of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.
Kaori HiraiDepartment of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.
Misato IzumiDepartment of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.
Yoshimi FukunoDepartment of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.
Mami TanakaDepartment of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.
Mai OkazakiDepartment of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.
Rongrong WuInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Yurika NishikawaInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Yusuke MatsuneInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Shunsuke ShibuiInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Yoshinori NakamoriInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Masafumi NishioInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Mao MatsubayashiInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Tsuyoshi OgashiwaInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Ayako FujiiInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Kenichiro ToritaniInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Hideaki KimuraInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Eita KumagaiDepartment of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Yukiko SasaharaDepartment of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Yoshiaki InayamaDepartment of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Satoshi FujiiDepartment of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Toshiaki EbinaDepartment of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.
Kazushi NumataDepartment of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.
Shin MaedaDepartment of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsIntestinal Behçet disease is typically associated with ileocecal punched-out ulcers and significant morbidity and mortality. Intestinal ultrasound is a noninvasive imaging technique for disease monitoring. However, no previous reports have compared intestinal ultrasound with endoscopic ulcer activity or histopathological findings for intestinal Behçet disease. We evaluated the usefulness of intestinal ultrasound for assessing the activity of ileocecal ulcers in intestinal Behçet disease.

methodsWe retrospectively compared intestinal ultrasound findings with 73 corresponding endoscopic images and 6 resected specimens. The intestinal ultrasound findings were assessed for 7 parameters (bowel wall thickness, vascularity [evaluated using the modified Limberg score with color Doppler], bowel wall stratification, white-plaque sign [strong hyperechogenic lines or spots], mesenteric lymphadenopathy, extramural phlegmons, and fistulas), and endoscopic ulcer activity was classified into active, healing, and scar stages. Histopathological findings were evaluated by consensus among experienced pathologists.

resultsBowel wall thickness (P< 0.001), vascularity (P< 0.001), loss of bowel wall stratification (P= 0.015), and white-plague sign (P= 0.013) were significantly exacerbated in the endoscopic active ulcer stage. Receiver operating characteristic curve analysis revealed that a bowel wall thickness of > 5.5 mm (sensitivity 89.7%, specificity 85.3%) was potentially useful for detecting active lesions. When compared with histopathological findings, an increase in bowel wall thickness reflected the ulcer marginal ridge, and the white-plaque sign reflected the ulcer bottom.

conclusionsIntestinal ultrasound is useful for monitoring intestinal ulcer activity in intestinal Behçet disease.

Indexed as

Behçet diseaseEndoscopyIntestinal diseasesUlcerUltrasonography

Identifiers

PMID39009376
PMCPMC11309824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.